Phase II Trial of FOLFOX in Combination With Cetuximab and Concomitant Radiotherapy in the Treatment of Esophageal Cancer Stage III
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2012
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Oesophageal cancer
- Focus Therapeutic Use
- Acronyms ERAFOX
- 04 Jul 2012 Last checked against European Clinical Trials Database record.
- 30 Mar 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 30 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.